CAPLYTA® showed greatest improvement across key efficacy outcomes among adjunctive MDD treatments in new network meta-analysis - Investing News Network

Submitted by Anonymous (not verified) on Mon, 05/04/2026 - 12:55

CAPLYTA® showed greatest improvement across key efficacy outcomes among adjunctive MDD treatments in new network meta-analysis  Investing News Network